Godmode

GodmodeHQ is an AI-powered sales platform that automates lead generation, research, and personalized outreach across multiple channels, enhancing B2B sales efficiency.

Headquarters

Year Founded

Search Tags

AI sales automation, AI-powered CRM integration, Autonomous lead generation, B2B sales intelligence, Personalized outreach AI

About Us

GodmodeHQ is an AI-powered sales intelligence platform that automates lead generation, account research, and personalized outreach for B2B sales teams. The platform uses AI agents to find leads, conduct in-depth research, and create tailored messages across multiple channels like LinkedIn, Gmail, and Slack. It integrates with popular CRM systems and B2B databases, consolidating sales conversations in a unified inbox. GodmodeHQ helps sales professionals focus on building relationships and closing deals by streamlining repetitive tasks and enhancing message personalization.

Trending Companies

Latest Articles

Engineer intelligent, AI-driven supply chain operations. Discover what next-generation leaders must master to design resilient, data-driven, high-performing global networks.

The Future of Supply Chain Leadership: Why the Next Generation Will Engineer Intelligence, Not Just Manage It

Supply chain leadership is being redefined by AI, intelligent automation, and agentic decision-making, demanding leaders who can engineer end-to-end intelligence rather than simply manage workflows. This article explores how next-generation supply chain leaders will combine data, algorithms, and human judgment to build resilient, adaptive, and high-performing global operations.

Read More >
Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >